听力与言语-语言病理学

行为科学

医学伦理学

你正在浏览Brachytherapy期刊下所有文献
  • First clinical implementation of GammaTile permanent brain implants after FDA clearance.

    abstract:PURPOSE:GammaTile cesium-131 (131Cs) permanent brain implant has received Food and Drug Administration (FDA) clearance as a promising treatment for certain brain tumors. Our center was the first institution in the United States after FDA clearance to offer the clinical use of GammaTile brachytherapy outside of a clinic...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.12.005

    authors: Ferreira C,Sterling D,Reynolds M,Dusenbery K,Chen C,Alaei P

    更新日期:2021-01-21 00:00:00

  • Substantial lymphovascular space invasion predicts worse outcomes in early-stage endometrioid endometrial cancer.

    abstract:INTRODUCTION:Substantial as opposed to focal or no lymphovascular space invasion (LVSI) is proposed as an independent adverse prognostic factor in patients with early-stage endometrioid endometrial cancer (EEC). We reviewed outcomes of patients treated with adjuvant vaginal brachytherapy (VB) alone in a single institut...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.12.006

    authors: Barnes EA,Martell K,Parra-Herran C,Taggar AS,Donovan E,Leung E

    更新日期:2021-01-20 00:00:00

  • Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.

    abstract:PURPOSE:Although surgery remains a treatment option for symptomatic brain metastases, the need for adjuvant radiation after surgery is widely accepted as standard. Despite a multitude of randomized trials aimed at identifying the ideal radiation treatment plan for surgically resected metastases, the development of new ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.11.004

    authors: Dahshan BA,Weir JS,Bice RP,Renz P,Cifarelli DT,Poplawski L,Hack J,Vargo JA,Cifarelli CP

    更新日期:2021-01-13 00:00:00

  • Radiation protection and dosimetry issues for patients with prostate cancer after I-125 low-dose-rate brachytherapy permanent implant.

    abstract:PURPOSE:The aim of this work was to analyze the exposure rates measured in the proximity of patients who underwent prostate low-dose-rate brachytherapy with I-125 implant. Effective doses to relatives and to population were computed to estimate the time to reach radioprotection dose constraints. METHODS AND MATERIALS:...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.09.003

    authors: Licciardello T,Feliciani G,Mazzotti G,Mostacci D,Sarnelli A,Menghi E

    更新日期:2021-01-01 00:00:00

  • #ThisIsBrachytherapy: Increasing awareness of brachytherapy.

    abstract:PURPOSE:The use of brachytherapy continues to be a vital application of radiation oncology for various cancers. Despite this, there has been a decrease in the utilization of brachytherapy in many cancers. Social media in medicine facilitates engagement and advocacy. We launched a social media campaign to bring awarenes...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.07.003

    authors: Kahn JM,Campbell SR,Albert AA,Knoll MA,Shah C

    更新日期:2021-01-01 00:00:00

  • Minimal channel GreenLight photovaporization before permanent implant prostate brachytherapy for patients with obstructive symptoms: Technically feasible and safe.

    abstract:PURPOSE:Brachytherapy (BrT) is a standard treatment for low-risk to favorable-intermediate-risk prostate cancer but is a relative contraindication for patients with obstructive symptoms. We aimed to assess the feasibility and urinary toxicity of a minimal photovaporization (mPVP) before implantation. MATERIALS AND MET...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.08.003

    authors: Peigne C,Fournier G,Dissaux G,Delage F,Coquet JB,Boussion N,Goasduff G,Malhaire JP,Pradier O,Schick U,Valeri A

    更新日期:2021-01-01 00:00:00

  • Salvage low-dose-rate brachytherapy for local recurrences after prostatectomy and adjuvant or salvage external beam irradiation: Feasibility study on five patients and literature review.

    abstract:PURPOSE:To assess the feasibility and tumor outcome of re-irradiation with low-dose-rate brachytherapy for macroscopic local recurrences after radical prostatectomy (RP) followed by adjuvant or salvage external beam radiation therapy (EBRT). METHODS AND MATERIALS:Between 2011 and 2018, five men with histologically pro...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.07.001

    authors: Le Roy C,Gassa F,Rouvière O,Desmettre O,Bringeon G,Charret J,Serre AA,Pommier P

    更新日期:2021-01-01 00:00:00

  • Review of brachytherapy complications - Upper gastrointestinal tract.

    abstract::While brachytherapy applications are not widely used for cancer diagnoses in the upper GI tract (including the esophagus, liver, stomach, and pancreas), they have a clear role in palliation and symptom management and occasionally definitive locoregional treatment. With the increasing use of image-guided techniques, th...

    journal_title:Brachytherapy

    pub_type: 杂志文章,评审

    doi:10.1016/j.brachy.2020.11.010

    authors: Folkert MR,Gottumukkala S,Nguyen NT,Taggar A,Sur RK

    更新日期:2020-12-22 00:00:00

  • Is stereotactic CyberKnife radiotherapy or multicatheter HDR brachytherapy the better option dosimetrically for accelerated partial breast irradiation?

    abstract:OBJECTIVE:To compare dosimetrically the stereotactic CyberKnife (CK) therapy and multicatheter high-dose-rate (HDR) brachytherapy (BT) for accelerated partial breast irradiation (APBI). METHODS:Treatment plans of 25 patients treated with CK were selected, and additional plans using multicatheter HDR BT were created on...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.10.003

    authors: Fröhlich G,Mészáros N,Smanykó V,Stelczer G,Herein A,Polgár C,Major T

    更新日期:2020-11-18 00:00:00

  • Evaluation of a collapsed-cone convolution algorithm for esophagus and surface mold 192Ir brachytherapy treatment planning.

    abstract:PURPOSE:TG43 does not account for a lack of scatter and tissue and applicator heterogeneities. The advanced collapsed-cone engine (ACE) algorithm available for use in the Oncentra Brachy treatment planning system (Elekta AB, Stockholm, Sweden) can model these conditions more accurately and is evaluated for esophageal a...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.09.006

    authors: Eason L,Mason J,Cooper R,Radhakrishna G,Bownes P

    更新日期:2020-10-15 00:00:00

  • Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy.

    abstract:PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.09.001

    authors: Boehle A,Katic K,König IR,Robrahn-Nitschke I,Brandenburg B

    更新日期:2020-01-01 00:00:00

  • Optimization of prostate brachytherapy techniques with polyethylene glycol-based hydrogel spacers: A systematic review.

    abstract:PURPOSE:The objective of this overview was to critically evaluate the effect of polyethylene glycol (PEG)-based hydrogel spacers during prostate brachytherapy with regard to dosimetric and clinical benefits, as well as procedure-related toxicity. METHODS AND MATERIALS:A systematic search in the PubMed database was per...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.08.009

    authors: Afkhami Ardekani M,Ghaffari H

    更新日期:2020-01-01 00:00:00

  • A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy.

    abstract:PURPOSE:The American Brachytherapy Society (ABS) consensus guidelines for high-dose-rate (HDR) prostate brachytherapy suggest 11 different dose constraints for the urethra. The purpose of this study is to evaluate whether a single urethral constraint of D0.1 cm3 < 110% could meet all the proposed ABS urethral constrain...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.12.001

    authors: Lu DJ,Phillips T,DeMarco J,Sandler HM,Kamrava M

    更新日期:2020-01-01 00:00:00

  • Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.

    abstract:PURPOSE:To analyze the dosimetric impact and periprocedural outcomes with a bioabsorbable hydrogel rectal spacer injected during low-dose-rate (LDR) prostate brachytherapy implants. METHODS AND MATERIALS:A consecutive series of 80 patients implanted with stranded I-125 LDR brachytherapy seeds were evaluated, of which ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.11.002

    authors: Kahn J,Dahman B,McLaughlin C,Kapoor P,Kapoor R,Harris E,Sharma M,Schutzer M,Moghanaki D

    更新日期:2020-01-01 00:00:00

  • Development of an indigenous low-cost multichannel cylinder applicator for vaginal tumors.

    abstract:PURPOSE:The purpose of this study was to report our experience regarding the development of a low-cost multichannel vaginal cylinder applicator for superficial and recurrent vaginal tumors. METHODS AND MATERIALS:The applicator mold was created by applying heated wax sheets in layers around a plastic tube. Interstitial...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.05.001

    authors: Bajwa HK,Singareddy R,Talluri AK,Guntupalli R,Raju AK,Sresty M,Ahmed A

    更新日期:2020-01-01 00:00:00

  • Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer.

    abstract::In 2008, the GEC ESTRO Gyn network launched the first multiinstitutional, observational, and prospective international study on MRI-guided brachytherapy in locally advanced cervical cancer patients (EMBRACE-I). EMBRACE-I was followed by EMBRACE-II from 2016 and ongoing. Among the aims of the EMBRACE studies are to ben...

    journal_title:Brachytherapy

    pub_type: 杂志文章,评审

    doi:10.1016/j.brachy.2020.08.011

    authors: Kirchheiner K,Smet S,Spampinato S,Jensen NBK,Vittrup AS,Fokdal L,Najjari-Jamal D,Westerveld HG,Lindegaard JC,Kirisits C,De Leeuw A,Schmid MP,Tan LT,Nout RA,Jürgenliemk-Schulz IM,Pötter R,Tanderup K,EMBRACE Collaborative

    更新日期:2020-01-01 00:00:00

  • MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy.

    abstract:PURPOSE:We sought to develop an activity nomogram for magnetic resonance (MR)-planned permanent seed prostate brachytherapy to improve quality assurance through a secondary dosimetric check. METHODS AND MATERIALS:Patients undergoing MRI-assisted radiosurgery (MARS), whereby MRI is used for preoperative planning and po...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.10.002

    authors: Hanania AN,Kudchadker RJ,Bruno TL,Tang C,Anscher MS,Frank SJ

    更新日期:2020-01-01 00:00:00

  • The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.

    abstract:PURPOSE:Education and training on prostate brachytherapy for radiation oncology and medical physics residents in the United States is inadequate, resulting in fewer competent radiation oncology personnel to perform implants, and is a factor in the subsequent decline of an important, potentially curative cancer treatmen...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.10.001

    authors: Frank SJ,Mourtada F,Crook J,Orio PF,Stock RG,Petereit DG,Rossi PJ,Cox BW,Tang C,Kudchadker RJ,Bruno T,Ma J,Sanders J,Keyes M

    更新日期:2020-01-01 00:00:00

  • Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy.

    abstract:PURPOSE:To validate the 2019 NCCN subgroups of favorable- and unfavorable-intermediate risk (IR) prostate cancer among patients treated with brachytherapy, who are underrepresented in the studies used to develop the 2019 NCCN classification. METHODS:We included all 2,705 men treated with I-125 LDR brachytherapy monoth...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.10.005

    authors: Tom MC,Reddy CA,Smile TD,Zhang RX,Ciezki JP,Stephans KL,Mian OY,Klein EA,Campbell S,Ulchaker J,Angermeier K,Tendulkar RD

    更新日期:2020-01-01 00:00:00

  • Novel and programmatic improvements to the workflow associated with the AccuBoost breast brachytherapy procedure.

    abstract:PURPOSE:While the noninvasive breast brachytherapy (NIBB) treatment procedure, known as AccuBoost, for breast cancer patients is well established, the treatment quality can be improved by the efficiency of the workflow delivery. A formalized approach evaluated the current workflow through failure modes and effects anal...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.01.007

    authors: Roles SA,Hepel JT,Leonard KL,Wazer DE,Cardarelli GA,Schwer ML,Saleh ZH,Klein EE,Brindle JM,Rivard MJ

    更新日期:2020-01-01 00:00:00

  • Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs.

    abstract:PURPOSE:African American men have historically had poorer prostate cancer biochemical and survival outcomes than Caucasians. However, emerging data suggest nononcologic factors drive much of this disparity. Prior evidence has suggested an association between a transient prostate specific antigen (PSA) bounce and improv...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.08.008

    authors: Slade AN,Dahman B,Chang MG

    更新日期:2020-01-01 00:00:00

  • High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique.

    abstract:PURPOSE:High-dose-rate (HDR) brachytherapy is a convenient treatment option for selected patients with T1-T2 penile squamous cell carcinoma (SCC), providing high rates of penile preservation and tumor control. We present the results of penile SCC treated with HDR brachytherapy either interstitially or via a surface mol...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.12.003

    authors: Marbán M,Crook J,Keyes M,Dubash R,Batchelar D

    更新日期:2020-01-01 00:00:00

  • Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone.

    abstract:PURPOSE:High-dose-rate (HDR) brachytherapy boost is a treatment of intermediate- to high-risk prostate cancer, but long-term clinical outcome data are sparse. We report long-term survival and toxicity data in a cohort of patients treated in a single institution. METHODS:Between 1998 and 2004, 654 patients with localiz...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.01.013

    authors: Kent AR,Matheson B,Millar JL

    更新日期:2019-01-01 00:00:00

  • Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.

    abstract:PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.05.005

    authors: Vuolukka K,Auvinen P,Palmgren JE,Voutilainen T,Aaltomaa S,Kataja V

    更新日期:2019-01-01 00:00:00

  • Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (

    abstract:PURPOSE:Patients with large prostate glands are underrepresented in clinical trials incorporating brachytherapy due to concerns for excessive toxicity. We sought to compare health-related quality of life (HRQOL) outcomes between small (<60 cc) and large (≥60 cc) prostates treated with high-dose-rate brachytherapy (HDR-...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.08.009

    authors: Press RH,Morgan TM,Cutrell PK,Zhang C,Chen Z,Rahnema S,Sanda M,Pattaras J,Patel P,Jani AB,Rossi PJ

    更新日期:2019-01-01 00:00:00

  • Patient-reported sexual adjustment after definitive chemoradiation and MR-guided brachytherapy for cervical cancer.

    abstract:PURPOSE:The treatment of locally advanced cervical cancer with definitive chemoradiation (CRT) is associated with vaginal toxicity and altered sexual satisfaction. This prospective study assessed patient-reported sexual adjustment, vaginal dosimetry, and physician-reported vaginal toxicity in patients with cervical can...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.09.005

    authors: Conway JL,Gerber R,Han K,Jiang H,Xie J,Beiki-Ardakani A,Fyles A,Milosevic M,Williamson D,Croke J

    更新日期:2019-01-01 00:00:00

  • Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.

    abstract:PURPOSE:To compare clinical outcomes between low-dose-rate (LDR) brachytherapy and high-dose-rate (HDR) brachytherapy for cervical cancer patients. METHODS AND MATERIALS:All consecutive newly diagnosed cervical cancer patients undergoing pretreatment 18-fluorodeoxyglucose positron emission tomography imaging and treat...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.11.008

    authors: Lin AJ,Samson P,Zoberi J,Garcia-Ramirez J,Williamson JF,Markovina S,Schwarz J,Grigsby PW

    更新日期:2019-01-01 00:00:00

  • High-dose-rate brachytherapy as monotherapy for prostate cancer: The impact of cellular repair and source decay.

    abstract:PURPOSE:This work quantifies the influence of intrafraction DNA damage repair and cellular repopulation on biologically effective dose (BED) in Ir-192 high-dose-rate brachytherapy for prostate cancer. In addition, it examines the effect of source-decay-induced BED variation for patients treated at different time points...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.04.005

    authors: Tien CJ,Carlson DJ,Nath R,Chen ZJ

    更新日期:2019-01-01 00:00:00

  • Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy.

    abstract:PURPOSE:Although current Delphi Consensus guidelines do not recommend a specific definition of biochemical recurrence after partial gland therapy, these guidelines acknowledge that serial prostate-specific antigen (PSA) tests remain the best marker for monitoring disease after treatment. The purpose of this study was t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.12.001

    authors: King MT,Nguyen PL,Boldbaatar N,Yang DD,Muralidhar V,Tempany CM,Cormack RA,Hurwitz MD,Suh WW,Pomerantz MM,D'Amico AV,Orio PF 3rd

    更新日期:2019-01-01 00:00:00

  • Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.

    abstract:PURPOSE:Marriage has been associated with enhanced survival among cancer patients, but conflicting correlations have been suggested in cervical cancer. We assessed the impact of marital status on receipt of brachytherapy and survival in women with locally advanced cervical cancer. METHODS AND MATERIALS:Three thousand,...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.04.273

    authors: Huynh-Le MP,Klapheke A,Cress R,Mell LK,Yashar CM,Einck JP,Mundt AJ,Mayadev JS

    更新日期:2019-01-01 00:00:00

  • Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity.

    abstract:PURPOSE:To improve efficiency, convenience, and cost, a prospective phase II trial was initiated to evaluate accelerated partial breast irradiation delivered with noninvasive image-guided breast brachytherapy (NIBB) via five once-daily fractions. METHODS AND MATERIALS:Women ≥50 years old with early-stage breast cancer...

    journal_title:Brachytherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.brachy.2018.05.006

    authors: Hepel JT,Yashar C,Leonard KL,Einck JP,Sha S,DiPetrillo T,Wiggins D,Graves TA,Edmonson D,Brown University Oncology Research Group.,Wazer DE

    更新日期:2018-01-01 00:00:00

  • Improving the treatment planning and delivery process of Xoft electronic skin brachytherapy.

    abstract:PURPOSE:To develop an improved Xoft electronic skin brachytherapy process and identify areas of further improvement. METHODS AND MATERIALS:A multidisciplinary team conducted a failure modes and effects analysis (FMEA) by developing a process map and a corresponding list of failure modes. The failure modes were scored ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.04.002

    authors: Manger R,Rahn D,Hoisak J,Dragojević I

    更新日期:2018-01-01 00:00:00

  • Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer.

    abstract:PURPOSE:In this planning study, we investigated the dosimetric benefit of repeat CT-based treatment planning at each fraction vs. the use of a single CT-based treatment plan for all fractions for high-dose-rate endorectal brachytherapy (HDREBT) for rectal cancer. METHODS AND MATERIALS:We included 11 patients that rece...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.08.011

    authors: van den Ende RPJ,Rijkmans EC,Kerkhof EM,Nout RA,Ketelaars M,Laman MS,Marijnen CAM,van der Heide UA

    更新日期:2018-01-01 00:00:00

  • Selection of patients who would not require long-term prostate-specific antigen monitoring after low-dose-rate brachytherapy.

    abstract:PURPOSE:To identify patients at extremely low risk of biochemical recurrence (BCR) of prostate cancer after low-dose-rate brachytherapy (LDR-BT) to determine when prostate-specific antigen (PSA) monitoring can be stopped. METHODS AND MATERIALS:We retrospectively reviewed clinicopathologic data of patients with prostat...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.08.018

    authors: Niwa N,Matsumoto K,Nishiyama T,Yagi Y,Ozu C,Nakamura K,Saito S,Oya M

    更新日期:2018-01-01 00:00:00

  • Comparison of spinal and general anesthesia approaches for MRI-guided brachytherapy for cervical cancer.

    abstract:PURPOSE:To evaluate the impact of general versus spinal anesthesia on postprocedure narcotic use and of extradepartmental planning MRI on treatment time in high-dose-rate brachytherapy for cervical cancer. METHODS AND MATERIALS:Twenty-five patients (10 general anesthesia and 15 spinal anesthesia) who collectively rece...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.05.002

    authors: Frankart AJ,Meier T,Minges TL,Kharofa J

    更新日期:2018-01-01 00:00:00

  • Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.

    abstract:PURPOSE:To recognize the practice of radiotherapy for management of cervical cancer in Ontario, Canada, and to use the results of the survey to harmonize and standardize practice across the province. METHODS AND MATERIALS:An electronic survey (SurveyMonkey) was sent to all 14 provincial cancer centers by Cancer Care O...

    journal_title:Brachytherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.brachy.2018.03.003

    authors: Shahid N,Craig T,Westerland M,Ashworth A,Ang M,D'Souza D,Sankreacha R,Fyles A,Milosevic M,Kong I,Cancer Care Ontario Radiation Treatment Gynecologic Oncology Community of Practice.

    更新日期:2018-01-01 00:00:00

  • In vivo dosimetry in gynecological applications-A feasibility study.

    abstract:PURPOSE:To investigate the feasibility of in vivo dosimetry using microMOSFET dosimeters in patients treated with brachytherapy using two types of gynecological applicators. METHODS AND MATERIALS:In this study, a microMOSFET was placed in an empty needle of an Utrecht Interstitial Fletcher applicator or MUPIT (Martine...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.04.240

    authors: Van Gellekom MPR,Canters RAM,Dankers FJWM,Loopstra A,van der Steen-Banasik EM,Haverkort MAD

    更新日期:2018-01-01 00:00:00

  • Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.

    abstract:PURPOSE:Given the limited data using an interstitial approach with 3D-based planning for definitive cervical cancer utilizing the GEC-ESTRO defined high-risk clinical target volume (HR-CTV), we reviewed our institutional experience of cervical cancer patients with HR-CTVs ≥ 30 cc to determine whether our clinical and t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.10.004

    authors: Wang C,Raince J,Swamy U,Park SJ,Zaide L,Mesko S,Demanes DJ,Kamrava M

    更新日期:2018-01-01 00:00:00

  • Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.

    abstract:PURPOSE:To evaluate the long-term disease control and toxicity to the organs at risk after dose-escalated image-based adaptive brachytherapy (BT) in cervical cancer. METHODS AND MATERIALS:Sixty patients of cervical cancer were treated with external radiotherapy 46 Gy in 23 fractions with weekly cisplatin and MRI-guide...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.09.008

    authors: Simha V,Rai B,Patel FD,Kapoor R,Sharma SC,Singh OA,Singla V,Dhanireddy B,Ghoshal S

    更新日期:2018-01-01 00:00:00

  • Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer.

    abstract:PURPOSE:The available data demonstrating that superiority of LDR brachytherapy (LDR-BT) boost in high-risk prostate cancer patients under represents patients with extracapsular extension (T3a) and/or seminal vesicle invasion (T3b) have been limited. We report long-term clinical outcomes data for patients with cT3a/b di...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.07.001

    authors: Agarwal M,Chhabra AM,Amin N,Braccioforte MH,Molitoris JK,Moran BJ

    更新日期:2018-01-01 00:00:00

142 条记录 1/4 页 « 1234 »